Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Wharton S, Batterham RL, Bhatta M, et al
Forest plot of GLP-1 receptor agonists versus comparators on the risk of pneumonia
In the peptide therapy context, AbbVie's Lupron (leuprolide) franchise treating prostate cancer, endometriosis, uterine fibroids, and precocious puberty via GnRH agonism remains a stable legacy contributor, while Botox Therapeutic ($748 million in Q1 2024 alone) constitutes a significant peptide-adjacent revenue stream
Jul 2013;7(14):188-98
Clinical Nutrition 37(3)
The compound elevates GH and IGF-1 within physiological ranges when administered at 2mg daily
US$ 29.41
US$ 27.75
US$ 20.34
